Immunohistochemical Detection of Estrogen Receptors in Canine Mammary Tumors

1. Moulton, J.E. (1990). Tumors of the mammary gland. In: Moulton J.E. (Ed.), Tumours in domestic animals (pp. 518–552). Berkeley: University of California Press.Search in Google Scholar

2. Sorenmo, K. (2003). Canine mammary gland tumors. Vet Clin North Am Small Anim Pract. 33, 573–596. http://dx.doi.org/10.1016/S0195-5616(03)00020-210.1016/S0195-5616(03)00020-2Search in Google Scholar

3. Hellmen, E. (2005). Complex mammary tumours in the female dog: a review. Journal of Dairy Research 72, 90–97. http://dx.doi.org/10.1017/S002202990500124X PMid:1618072610.1017/S002202990500124XSearch in Google Scholar

4. Sorenmo, K.U., Kristiansen, V.M., Cofone, M.A., Shofer, F.S., Breen, A.M., Langeland, M., Mongil, C.M., Grondahl, A.M., Teige, J., Goldschmidt, M.H. (2009). Canine mammary gland tumours: a histological continuum from benign to malignant, clinical and histopathological evidence. Vet Comp Oncol. 7, 162–172. http://dx.doi.org/10.1111/j.1476-5829.2009.00184.x PMid:1969164510.1111/j.1476-5829.2009.00184.x19691645Search in Google Scholar

5. Misdorp, W. (2002). Tumors of the mammary gland. In: Meuten D.J. (Ed.), Tumors in domestic animals (pp. 575–606). Ames: Iowa State Press. http://dx.doi.org/10.1002/9780470376928.ch1210.1002/9780470376928.ch12Search in Google Scholar

6. MacEwen, E.G., Withrow, S. (1996). Tumors of the mammary gland. Small Animal Oncology (pp. 356–372). Philadelphia: Saunders Company.Search in Google Scholar

7. De Las Mulas, J. M., Millán, Y., Dios, R. (2005). A prospective analysis of immunohistochemically determined estrogen receptor α and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog. Veterinary Pathology Online 42 (2): 200-212. http://dx.doi.org/10.1354/vp.42-2-200 PMid:1575347410.1354/vp.42-2-20015753474Search in Google Scholar

8. Nieto, A., Pena, L., Pérez-Alenza, M. D., Sanchez, M. A., Flores, J.M., Castano, M. (2000). Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Vet Pathol. 37 (3): 239–247. http://dx.doi.org/10.1354/vp.37-3-239 PMid:1081098810.1354/vp.37-3-23910810988Search in Google Scholar

9. Lana, S.E., Rutteman, G.R., Withrow, S.J. (2007). Tumors of the mammary gland. In: Withrow S.J & MacEwen B.R. (Ed.), Small animal clinical oncology (pp. 455-477). Philadelphia: Saunders Company. http://dx.doi.org/10.1016/B978-072160558-6.50029-010.1016/B978-072160558-6.50029-0Search in Google Scholar

10. Murphy, S. (2008). Mammary tumours in dogs and cats. Inpractice 6, 334–339. http://dx.doi.org/10.1136/inpract.30.6.33410.1136/inpract.30.6.334Search in Google Scholar

11. Beauvais, W., Cardwell, J. M., Brodbelt, D. C. (2012). The effect of neutering on the risk of mammary tumours in dogs – a systematic review. J Small Anim Pract. 53, 314–322. http://dx.doi.org/10.1111/j.1748-5827.2011.01220.x PMid:2264721010.1111/j.1748-5827.2011.01220.x22647210Search in Google Scholar

12. Las Mulas, J.M., Millan, Y., Dios R. (2005). A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog. Vet Pathol. 42, 200-212. http://dx.doi.org/10.1354/vp.42-2-200 PMid:1575347410.1354/vp.42-2-200Search in Google Scholar

13. Cork, D. M. W., Lennard, T. W. J., Tyson-Capper, A. J. (2008). Alternative splicing and the progesterone receptor in breast cancer. Breast Cancer Res. 10 (3): 207. http://dx.doi.org/10.1186/bcr2097 PMid:18557990 PMCid:PMC248149310.1186/bcr2097248149318557990Search in Google Scholar

14. Misdorp, W., Hellmen, E., Else, R.W. (1999). Mammary tumours and dysplasia in dogs and cats. Histologic classification of tumours of domestic animals. Second series (pp. 3-6). Washington DC: Armed Forces Institute of Pathology.Search in Google Scholar

15. Sorenmo, K.U., Shoferm, F.S., Goldschmidt, M.H. (2000). Effect of spaying and timing of spaying on survival of dogs with mammary carcinoma. J Vet Intern Med. 14, 266–270. http://dx.doi.org/10.1111/j.1939-1676.2000.tb01165.x PMid:1083053910.1111/j.1939-1676.2000.tb01165.xSearch in Google Scholar

16. Thuroczy, J., Reisvaag, G. J. K., Perge, E., Tibold, A., Szilagyi, J., Balogh, L. (2007). Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours. J Comp Pathol. 137 (2-3): 122–129. http://dx.doi.org/10.1016/j.jcpa.2007.05.005 PMid:1764588810.1016/j.jcpa.2007.05.00517645888Search in Google Scholar

17. Diaz, L. K., Sneige, N. (2005). Estrogen receptor analysis for breast cancer: current issues and keys to increasing testing accuracy. Adv Anat Pathol. 12 (1): 10–19. http://dx.doi.org/10.1097/00125480-200501000-00003 PMid:1561416010.1097/00125480-200501000-0000315614160Search in Google Scholar

18. Port Louis, L.R., Varshney, K.C., Nair, M.G. (2012). An immunohistochemical study on the expression of sex steroid receptors in canine mammary tumors. ISRN VetSci. 1-7. http://dx.doi.org/10.5402/2012/378607 PMid:23738123 PMCid:PMC365858210.5402/2012/378607365858223738123Search in Google Scholar

19. Rutteman, G.R., Misdorpl, W., Blankenstein, M.A., Van den Brom, W.E. (1988). Oestrogen (ER) and progestin receptors (PR) in mammary tissue of the female dog: Different receptor profile in non-malignant and malignant states. Br J Cancer. 58, 594-599. http://dx.doi.org/10.1038/bjc.1988.266 PMid:3219269 PMCid:PMC224683510.1038/bjc.1988.26622468353219269Search in Google Scholar

20. Mariotti, F., Giacomo, R., Subeide, M. (2013). Immunohistochemical evaluation of ovarian hormonal receptors in canine mammary tumors. Open J Vet Med. 3, 104-110. http://dx.doi.org/10.4236/ojvm.2013.3201710.4236/ojvm.2013.32017Search in Google Scholar

21. Spoerri, M., Guscetti, F., Hartnack, S., Boos, A., Oei, C., Balogh, O., Nowaczyk, R. M., Michel, E., Reichler, I. M., Kowalewski, M. P. (2015). Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors. BMC Vet Res. 11, 235. http://dx.doi.org/10.1186/s12917-015-0546-y PMid:26370564 PMCid:PMC457062310.1186/s12917-015-0546-y457062326370564Search in Google Scholar

22. Chen, Y.M., Lee, C.S., Wright, P.J. (2006). The roles of progestagen and uterine irritant in the maintenance of cystic endometrial hyperplasia in the canine uterus. Theriogenology 66, 1537–1544. http://dx.doi.org/10.1016/j.theriogenology.2006.01.019 PMid:1647285410.1016/j.theriogenology.2006.01.01916472854Search in Google Scholar

23. Hagman, R. (2014). Diagnostic and prognostic markers for uterine diseases in dogs. Reprod Dom Anim. 49 (2): 16–20. http://dx.doi.org/10.1111/rda.12331 PMid:2494785610.1111/rda.1233124947856Search in Google Scholar

24. Queiroga, F.L., Perez-Alenza, M.D., Silvan, G., Pena, L., Lopes, C., Illera, J.C. (2005). Role of steroid hormones and prolactin in canine mammary cancer. J Steroid Biochem Mol Biol. 94, 181–187. http://dx.doi.org/10.1016/j.jsbmb.2004.12.014 PMid:1586296410.1016/j.jsbmb.2004.12.01415862964Search in Google Scholar